CA2259353A1 - Emplatre pour l'utilisation transdermique de pergolide - Google Patents

Emplatre pour l'utilisation transdermique de pergolide

Info

Publication number
CA2259353A1
CA2259353A1 CA002259353A CA2259353A CA2259353A1 CA 2259353 A1 CA2259353 A1 CA 2259353A1 CA 002259353 A CA002259353 A CA 002259353A CA 2259353 A CA2259353 A CA 2259353A CA 2259353 A1 CA2259353 A1 CA 2259353A1
Authority
CA
Canada
Prior art keywords
pergolide
plaster
transdermal application
transdermal
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002259353A
Other languages
English (en)
Other versions
CA2259353C (fr
Inventor
Wilfried Fischer
Anna Sendl-Lang
Dagmar Zeh-Herwerth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19626621A external-priority patent/DE19626621A1/de
Application filed by Individual filed Critical Individual
Publication of CA2259353A1 publication Critical patent/CA2259353A1/fr
Application granted granted Critical
Publication of CA2259353C publication Critical patent/CA2259353C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002259353A 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide Expired - Fee Related CA2259353C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19626621A DE19626621A1 (de) 1996-07-02 1996-07-02 Pflaster zur transdermalen Anwendung von Pergolid
DE19626621.1 1996-07-02
PCT/EP1997/003458 WO1998000142A1 (fr) 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide

Publications (2)

Publication Number Publication Date
CA2259353A1 true CA2259353A1 (fr) 1998-01-08
CA2259353C CA2259353C (fr) 2006-09-05

Family

ID=36968407

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259353A Expired - Fee Related CA2259353C (fr) 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide

Country Status (1)

Country Link
CA (1) CA2259353C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461636B1 (en) * 1998-05-15 2002-10-08 Schwarz Pharma Ag Transdermal therapeutic system containing pergolide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461636B1 (en) * 1998-05-15 2002-10-08 Schwarz Pharma Ag Transdermal therapeutic system containing pergolide

Also Published As

Publication number Publication date
CA2259353C (fr) 2006-09-05

Similar Documents

Publication Publication Date Title
AU4477597A (en) New pharmaceutically active compounds
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
AU7224396A (en) Pharmaceutically active quinazoline compounds
WO2000057900A3 (fr) Facteur
KR20010012511A (ko) 약리학적 활성 물질을 제조하기 위한 신규한 방법
GR3036669T3 (en) O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
AU2186797A (en) Pharmaceutically useful compounds
EP1017980A4 (fr) Procede d'identification de composes pharmaceutiquement actifs
AU1819897A (en) Medicinal prophylactic "trisan"
AU4656596A (en) Transdermal formulation
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU4774296A (en) Transdermal formulation
AU5965399A (en) Pharmaceutically active composition
AU4914396A (en) Transdermal formulation
AU699195B2 (en) Method for the preparation of substituted 3-(phenylimino)- 3H-phenothiazines and phenoxazines
AU5095698A (en) Transdermal patch
DK0910379T3 (da) Plaster til transdermal påføring af pergolid
AU6821196A (en) Transdermal administration of vorozole
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
AU4143397A (en) New pharmaceutically active compounds
AU3347493A (en) Pharmaceutically active substituted benzimidazole derivatives
AU3853097A (en) Benzimidazole derivatives, preparation thereof, and therapeutical uses thereof
CA2259353A1 (fr) Emplatre pour l'utilisation transdermique de pergolide
AU5531798A (en) Pharmacologically active compounds and use
AU3128197A (en) Guanidino derivatives as inhibitors of the cytotoxic effect of peroxynitrite

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed